Literature DB >> 24371229

Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment.

Monica S Charpentier1, Rebecca A Whipple, Michele I Vitolo, Amanda E Boggs, Jana Slovic, Keyata N Thompson, Lekhana Bhandary, Stuart S Martin.   

Abstract

Cancer stem-like cells (CSC) and circulating tumor cells (CTC) have related properties associated with distant metastasis, but the mechanisms through which CSCs promote metastasis are unclear. In this study, we report that breast cancer cell lines with more stem-like properties display higher levels of microtentacles (McTN), a type of tubulin-based protrusion of the plasma cell membrane that forms on detached or suspended cells and aid in cell reattachment. We hypothesized that CSCs with large numbers of McTNs would more efficiently attach to distant tissues, promoting metastatic efficiency. The naturally occurring stem-like subpopulation of the human mammary epithelial (HMLE) cell line presents increased McTNs compared with its isogenic non-stem-like subpopulation. This increase was supported by elevated α-tubulin detyrosination and vimentin protein levels and organization. Increased McTNs in stem-like HMLEs promoted a faster initial reattachment of suspended cells that was inhibited by the tubulin-directed drug, colchicine, confirming a functional role for McTNs in stem cell reattachment. Moreover, live-cell confocal microscopy showed that McTNs persist in breast stem cell mammospheres as flexible, motile protrusions on the surface of the mammosphere. Although exposed to the environment, they also function as extensions between adjacent cells along cell-cell junctions. We found that treatment with the breast CSC-targeting compound curcumin rapidly extinguished McTN in breast CSC, preventing reattachment from suspension. Together, our results support a model in which breast CSCs with cytoskeletal alterations that promote McTNs can mediate attachment and metastasis but might be targeted by curcumin as an antimetastatic strategy. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371229      PMCID: PMC3990412          DOI: 10.1158/0008-5472.CAN-13-1778

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models.

Authors:  Huiping Liu; Manishkumar R Patel; Jennifer A Prescher; Antonia Patsialou; Dalong Qian; Jiahui Lin; Susanna Wen; Ya-Fang Chang; Michael H Bachmann; Yohei Shimono; Piero Dalerba; Maddalena Adorno; Neethan Lobo; Janet Bueno; Frederick M Dirbas; Sumanta Goswami; George Somlo; John Condeelis; Christopher H Contag; Sanjiv Sam Gambhir; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.

Authors:  A Mialhe; L Lafanechère; I Treilleux; N Peloux; C Dumontet; A Brémond; M H Panh; R Payan; J Wehland; R L Margolis; D Job
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Breast cancer metastasis: challenges and opportunities.

Authors:  Jing Lu; Patricia S Steeg; Janet E Price; Savitri Krishnamurthy; Sendurai A Mani; James Reuben; Massimo Cristofanilli; Gabriela Dontu; Luc Bidaut; Vicente Valero; Gabriel N Hortobagyi; Dihua Yu
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

Review 4.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

5.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

6.  Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

Authors:  Benny K Abraham; Peter Fritz; Monika McClellan; Petra Hauptvogel; Maria Athelogou; Hiltrud Brauch
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

7.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 8.  Cancer stem cells in breast cancer and metastasis.

Authors:  Jessica C Lawson; Gregory L Blatch; Adrienne L Edkins
Journal:  Breast Cancer Res Treat       Date:  2009-11       Impact factor: 4.872

9.  An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization.

Authors:  Tsukasa Shibue; Mary W Brooks; Robert A Weinberg
Journal:  Cancer Cell       Date:  2013-09-12       Impact factor: 31.743

10.  Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatment.

Authors:  Anna L Palange; Daniele Di Mascolo; Jaykrishna Singh; Maria S De Franceschi; Claudio Carallo; Agostino Gnasso; Paolo Decuzzi
Journal:  Front Oncol       Date:  2012-11-15       Impact factor: 6.244

View more
  37 in total

Review 1.  Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.

Authors:  James A McCubrey; Kvin Lertpiriyapong; Linda S Steelman; Steve L Abrams; Li V Yang; Ramiro M Murata; Pedro L Rosalen; Aurora Scalisi; Luca M Neri; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Piotr Laidler; Joanna Dulińska-Litewka; Dariusz Rakus; Agnieszka Gizak; Paolo Lombardi; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Giuseppe Montalto; Melchiorre Cervello
Journal:  Aging (Albany NY)       Date:  2017-06-12       Impact factor: 5.682

Review 2.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

3.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

Review 4.  Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth.

Authors:  Kristi R Chakrabarti; Lindsay Hessler; Lekhana Bhandary; Stuart S Martin
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

5.  Suspension state regulates epithelial-to-mesenchymal transition and stemness of breast tumor cells.

Authors:  Yonggang Lv; Xiaomei Zhang; Lini Chen
Journal:  Biotechnol Lett       Date:  2021-01-02       Impact factor: 2.461

Review 6.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

Review 7.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

8.  Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis.

Authors:  Julia A Ju; Cornell J Lee; Keyata N Thompson; Eleanor C Ory; Rachel M Lee; Trevor J Mathias; Stephen J P Pratt; Michele I Vitolo; Christopher M Jewell; Stuart S Martin
Journal:  Lab Chip       Date:  2020-08-03       Impact factor: 6.799

Review 9.  Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant
Journal:  Semin Cancer Biol       Date:  2016-09-05       Impact factor: 15.707

Review 10.  Colchicine--Update on mechanisms of action and therapeutic uses.

Authors:  Ying Ying Leung; Laura Li Yao Hui; Virginia B Kraus
Journal:  Semin Arthritis Rheum       Date:  2015-06-26       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.